Exciting news from PAVIS Engineering!
We’ve been awarded the contract to automate one of the world’s largest monoclonal antibody production facilities – a major step forward in the fight against cancer.
With our proven PCS7 integration expertise and the support of our expert network, we are working at full speed to ensure a smooth and timely production start for our customer.
PAVIS is generating rMTP files for the entire facility. This will make it the first plant worldwide to be fully specified using rMTP – a true milestone in automation technology.
We’re proud to contribute not only on a technical level, but to something that truly makes a difference.
More updates to follow.